• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性遗传性运动障碍与癫痫

Paroxysmal Genetic Movement Disorders and Epilepsy.

作者信息

de Gusmão Claudio M, Garcia Lucas, Mikati Mohamad A, Su Samantha, Silveira-Moriyama Laura

机构信息

Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States.

Department of Neurology, Universidade Estadual de Campinas (UNICAMP), São Paulo, Brazil.

出版信息

Front Neurol. 2021 Mar 23;12:648031. doi: 10.3389/fneur.2021.648031. eCollection 2021.

DOI:10.3389/fneur.2021.648031
PMID:33833732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021799/
Abstract

Paroxysmal movement disorders include paroxysmal kinesigenic dyskinesia, paroxysmal non-kinesigenic dyskinesia, paroxysmal exercise-induced dyskinesia, and episodic ataxias. In recent years, there has been renewed interest and recognition of these disorders and their intersection with epilepsy, at the molecular and pathophysiological levels. In this review, we discuss how these distinct phenotypes were constructed from a historical perspective and discuss how they are currently coalescing into established genetic etiologies with extensive pleiotropy, emphasizing clinical phenotyping important for diagnosis and for interpreting results from genetic testing. We discuss insights on the pathophysiology of select disorders and describe shared mechanisms that overlap treatment principles in some of these disorders. In the near future, it is likely that a growing number of genes will be described associating movement disorders and epilepsy, in parallel with improved understanding of disease mechanisms leading to more effective treatments.

摘要

发作性运动障碍包括发作性运动诱发性运动障碍、发作性非运动诱发性运动障碍、发作性运动诱发的运动障碍和发作性共济失调。近年来,在分子和病理生理学层面,人们对这些疾病及其与癫痫的交叉关系重新产生了兴趣并获得了认识。在这篇综述中,我们从历史角度讨论这些不同表型是如何构建的,并讨论它们目前如何合并为具有广泛多效性的既定遗传病因,强调临床表型分析对于诊断和解释基因检测结果的重要性。我们讨论了对某些疾病病理生理学的见解,并描述了一些这些疾病中重叠治疗原则的共同机制。在不久的将来,可能会有越来越多的基因被描述与运动障碍和癫痫相关联,同时对疾病机制的理解也会得到改善,从而带来更有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/8021799/6b4316ce4f77/fneur-12-648031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/8021799/6b4316ce4f77/fneur-12-648031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c73e/8021799/6b4316ce4f77/fneur-12-648031-g0001.jpg

相似文献

1
Paroxysmal Genetic Movement Disorders and Epilepsy.阵发性遗传性运动障碍与癫痫
Front Neurol. 2021 Mar 23;12:648031. doi: 10.3389/fneur.2021.648031. eCollection 2021.
2
The evolving spectrum of PRRT2-associated paroxysmal diseases.PRRT2 相关性阵发性疾病谱的演变。
Brain. 2015 Dec;138(Pt 12):3476-95. doi: 10.1093/brain/awv317. Epub 2015 Nov 23.
3
The clinical and genetic heterogeneity of paroxysmal dyskinesias.发作性运动障碍的临床和遗传异质性。
Brain. 2015 Dec;138(Pt 12):3567-80. doi: 10.1093/brain/awv310. Epub 2015 Nov 23.
4
Paroxysmal movement disorders: Paroxysmal dyskinesia and episodic ataxia.发作性运动障碍:发作性运动障碍和发作性共济失调。
Handb Clin Neurol. 2023;196:347-365. doi: 10.1016/B978-0-323-98817-9.00033-8.
5
Paroxysmal movement disorders.阵发性运动障碍。
Handb Clin Neurol. 2024;203:145-156. doi: 10.1016/B978-0-323-90820-7.00010-0.
6
mutation in a Japanese woman: Adult-onset focal epilepsy coexisting with movement disorders and cerebellar atrophy.一名日本女性的突变:成人起病的局灶性癫痫合并运动障碍和小脑萎缩。
Epilepsy Behav Rep. 2022 May 18;19:100554. doi: 10.1016/j.ebr.2022.100554. eCollection 2022.
7
PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.中国阵发性运动诱发性运动障碍家系队列中的PRRT2突变及文献中的基因型-表型相关性再分析
Int J Neurosci. 2018 Aug;128(8):751-760. doi: 10.1080/00207454.2017.1418345. Epub 2018 Jan 7.
8
Genetic Links to Episodic Movement Disorders: Current Insights.发作性运动障碍的遗传联系:当前见解
Appl Clin Genet. 2023 Mar 1;16:11-30. doi: 10.2147/TACG.S363485. eCollection 2023.
9
[Familial paroxysmal kinesigenic dyskinesia. A case description].[家族性阵发性运动诱发性运动障碍。病例描述]
An Pediatr (Barc). 2015 Jan;82(1):e154-7. doi: 10.1016/j.anpedi.2014.07.020. Epub 2014 Sep 7.
10
Paroxysmal Non-Kinesigenic Choreoathetosis Case Report and a Review of the Pathogenesis.阵发性非运动诱发性舞蹈手足徐动症病例报告及发病机制综述
Cureus. 2022 Feb 1;14(2):e21804. doi: 10.7759/cureus.21804. eCollection 2022 Feb.

引用本文的文献

1
Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons.揭示钠钾ATP酶泵的作用:神经退行性机制与治疗前景
Pharmacol Rep. 2025 Jun;77(3):576-592. doi: 10.1007/s43440-025-00717-6. Epub 2025 Mar 21.
2
Canine paroxysmal dyskinesia-a review.犬阵发性运动障碍——综述
Front Vet Sci. 2024 Jul 18;11:1441332. doi: 10.3389/fvets.2024.1441332. eCollection 2024.
3
Low-intensity exercise combined with sodium valproate attenuates kainic acid-induced seizures and associated co-morbidities by inhibiting NF-κB signaling in mice.

本文引用的文献

1
Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations.早发性严重 ATP1A2 癫痫性脑病:临床特征及潜在突变。
Epilepsy Behav. 2021 Mar;116:107732. doi: 10.1016/j.yebeh.2020.107732. Epub 2021 Jan 23.
2
Clinical phenotypes of infantile onset CACNA1A-related disorder.婴儿期起病的 CACNA1A 相关性疾病的临床表型。
Eur J Paediatr Neurol. 2021 Jan;30:144-154. doi: 10.1016/j.ejpn.2020.10.004. Epub 2020 Oct 20.
3
Tics induced by antiepileptic drugs: a pragmatic review.抗癫痫药物诱发的抽搐:实用综述。
低强度运动联合丙戊酸钠通过抑制小鼠体内的NF-κB信号通路减轻 kainic 酸诱导的癫痫发作及相关合并症。
Front Neurol. 2022 Sep 21;13:993405. doi: 10.3389/fneur.2022.993405. eCollection 2022.
4
Damaging novel mutations in PIGN cause developmental epileptic-dyskinetic encephalopathy: a case report.PIGN 中致病变异导致发育性癫痫性脑病伴多动:病例报告。
BMC Pediatr. 2022 Apr 25;22(1):222. doi: 10.1186/s12887-022-03246-w.
5
Case Report: A Case of Concomitant Paroxysmal Kinesigenic Dyskinesia and Epilepsy: Can We Treat Two Birds With One Stone?病例报告:一例阵发性运动诱发性运动障碍合并癫痫:我们能一石二鸟吗?
Front Neurol. 2022 Feb 2;13:826897. doi: 10.3389/fneur.2022.826897. eCollection 2022.
6
Editorial: Genetics of Paroxysmal Movement Disorders.社论:发作性运动障碍的遗传学
Front Neurol. 2021 Sep 28;12:752000. doi: 10.3389/fneur.2021.752000. eCollection 2021.
7
Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in -Associated Episodic Ataxia and a Comprehensive Review of the Literature.钠通道阻滞剂作为发作性共济失调相关靶向治疗方法的治疗潜力及文献综述
Front Neurol. 2021 Sep 9;12:703970. doi: 10.3389/fneur.2021.703970. eCollection 2021.
J Neurol. 2021 Jan;268(1):321-336. doi: 10.1007/s00415-020-10153-6. Epub 2020 Aug 17.
4
D-DEMØ, a distinct phenotype caused by mutations.D-DEMØ,一种由突变引起的独特表型。
Neurol Genet. 2020 Aug 4;6(5):e466. doi: 10.1212/NXG.0000000000000466. eCollection 2020 Oct.
5
Kinesigenic Triggers in Episodic Ataxia Type 1.发作性共济失调1型中的运动诱发性触发因素
Mov Disord Clin Pract. 2020 Jul 19;7(6):723-724. doi: 10.1002/mdc3.13008. eCollection 2020 Aug.
6
Functional consequences of SLC1A3 mutations associated with episodic ataxia 6.SLC1A3 突变与发作性共济失调 6 型相关的功能后果。
Hum Mutat. 2020 Nov;41(11):1892-1905. doi: 10.1002/humu.24089. Epub 2020 Sep 9.
7
Severe paroxysmal dyskinesias without epilepsy in a RHOBTB2 mutation carrier.一名RHOBTB2突变携带者出现无癫痫的严重阵发性运动障碍。
Parkinsonism Relat Disord. 2020 Aug;77:87-88. doi: 10.1016/j.parkreldis.2020.06.028. Epub 2020 Jun 29.
8
A Gain-of-Function Mutation in KCNMA1 Causes Dystonia Spells Controlled With Stimulant Therapy.KCNMA1 上的功能获得性突变导致与兴奋剂治疗相关的肌张力障碍发作。
Mov Disord. 2020 Oct;35(10):1868-1873. doi: 10.1002/mds.28138. Epub 2020 Jul 7.
9
Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review.卡马西平、奥卡西平、依沙佐匹坦相关运动障碍:文献综述。
Clin Neuropharmacol. 2020 May/Jun;43(3):66-80. doi: 10.1097/WNF.0000000000000387.
10
Clinical Spectrum of Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.突变的临床谱:对发作性共济失调和癫痫共病的新认识。
Int J Mol Sci. 2020 Apr 17;21(8):2802. doi: 10.3390/ijms21082802.